美股新聞 標題聯播 · 近 24 小時 336 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · OPK近 30 天 5 則 · 第 1 / 1 頁
- OPKO Health (OPK) Cashes In A Future Royalty Stream Early
- Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
- Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
- Cocrystal Pharma: The Strategic Reset Investors May Be Missing
- Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report?
- COCP: $5 Million Private Placement with OPKO Health
- OPK Raises $125 Million Against Royalties: What Investors Should Know
- OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?
- OPKO Health Secures $125 Million Financing Against Mazdutide Royalties
- OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
- OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know
- Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
- OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。